Discover and read the best of Twitter Threads about #GeneEditing

Most recents (24)

1/As promised & after reading $CRSP latest Q4 2022 #financial #report here is my impression regarding @CRISPRTX latest corporate status. I have focused only on the main issues that I found to be the most interesting & relevant. #CRISPR #BioTech #FinTwit #Genomics #GeneEditing 🧵 CRISPR Therapeutics, a biopharmaceutical company focused on
2/IMO the most significant corporate event in Q4 was $CRSP announcement that regulatory Exa-cel submissions of both #SickleCell & #BetaThalassemia validated in the #EU & #UK & that the @US_FDA BLA submission is on track by the end of Q1 ‘23 - possibly reaching the #markets in ‘23 Regulatory submissions complete for exagamglogene autotemcel
3/Exa-cel/CTX001 - the key program in $CRSP portfolio, is an #autologous Ex-Vivo #CRISPR/#Cas9 #GeneEditing therapy aimed for patients suffering from #TDT or severe #SCD. The latest readout for both programs was phenomenal with 42/44 TDT & 31/31(!) demonstrated remarkable results 3/Exa-cel - formally known as CTX001 and the key program in
Read 17 tweets
1/@LineageCell announced it entered an exclusive option & license agreement with $ERNA for the development of novel B2M deficient induced pluripotent #stem #cell #iPSC by using Eterna’s #GeneEditing technology thus developing therapies for #CNS diseases. #BioTech #CRISPR $LCTX Lineage Cell Therapeutics, ...
2/The new cell lines - to be developed by $ERNA, will support the creation of additional product candidates at $LCTX and specifically for the treatment of central #nervoussystem #CNS disorders & other #neurology targets via Eterna’s IP #CRISPR collaboration with @FactorBio The new cell lines to be de...
3/This agreement will also allow @LineageCell to enter the #CRISPR field and will provide $LCTX an option to obtain an exclusive license to utilize & sublicense $ERNA novel #GeneEditing cell lines for #preclinical, #clinical, & commercial purposes in the field of CNS diseases. This agreement will also al...
Read 5 tweets
Our story on inserting short sequences with prime editing is now online @NatureBiotech.

nature.com/articles/s4158…

So much has changed from the preprint including the discovery that 3'-flap nucleases can inhibit the insertion of long inserts. Lots to unpack 🧵 Image
A quick recap: We wanted to understand what factors influence how well a given sequence can be inserted with prime editing. To experimentally test this, we integrated 3,604 pegRNAs into 4 target sites in three cell lines and measured their insertion rates
Our cell lines differed in their mismatch repair status and we recapitulate the well-known effects of MMR in inhibiting the insertion of short sequences with our libraries.
sciencedirect.com/science/articl…
nature.com/articles/s4146…
Read 16 tweets
🧵You can own the Future of Tomorrow Today.

I have heard many people try to call this crash in biotech the end of the #Biotechnology sector. A sector that has been around for decades. One of the most necessary sectors in the entire market.
1/ Here I am going to lay out for you the opposite case. I have been investing in tech and biotech for 27 years. I have seen so much technology that excites me about the future, and I see it today.
2/ The biggest question I always get in biotech investing is when will we run out of things to discover or great new technologies to invent. I my response is we will never run out until we cure every disease.
Read 19 tweets
1/@GraphiteBio presented preclinical results supporting the use of a single-#cell #RNA #sequencing method to assess #gene correction outcomes in #patients treated with nulabeglogene autogedtemcel (nula-cel) - GPH-101. #BioTech #CRISPR #GeneEditing #Genomics $GRPH #ASH22 GraphiteBio presented precl...
2/GPH101 (nula-cel) is a #CRISPR #Cas9 #GeneEditing autologous #stem #cell-based #therapy in clinical development aimed to treat #SickleCellDisease. GPH101 is designed to directly correct the underlying mutation, thereby decreasing HbS production & restoring HbA expression #ASH22 GPH101 (nula-cel) is a CRIS...
3 $GRPH gene correction platform involves editing hematopoietic #stem cells found in the #bonemarrow that develop into various types of #blood #cells. Since red blood cells lose their genomic DNA during maturation-tracking #GeneEditing in mature cells via sequencing is impossible Graphite bio’s gene correct...
Read 7 tweets
The Great Ormond Street Hospital for Children in London has preformed the world's first base editing treatment for a 13-year-old patient's once "incurable" T-cell leukemia to rid her body of cancer. #cancer #geneediting #baseediting #cancertreatment #Leukemia #CGTNAmerica
Invented six years ago, base editing uses the four bases of the building blocks of the human genetic code: adenine (A), cytosine (C), guanine (G) and thymine (T). #cancer #geneediting #baseediting #newcancertreatment #cancertreatment #Leukemia #CGTNAmerica
Scientists alter the structure of a base, converting it to another and changing the genetic instructions. The hospital used this technology to edit and create a new type of T-cell that finds and destroys T-cells, including leukemic T-cells. #geneediting #baseediting #Leukemia
Read 4 tweets
🧵 My “One Thread to Rule Them All” for $BEAM

Attempting to estimate revenues ‘til 2031

⚠️ Warning: This is VERY long

Figures are “Blue Sky Scenario”

At the end I’ll throw in more conservative estimates

🚨 If you love BEAM or #GeneEditing + #CRISPR be sure to LIKE & RETWEET!
$BEAM-101

Approval: 1H 2027

Wave 1 Market: 25k US/14k EU

Market in 4 years: ~27k total ($CRSP/$BLUE)

Cost: ~2m

27’: 500 patients= 1b
28’: 2000 patients= 4b
29’: 1b (ESCAPE looming)
30’: zero
31’: zero
$BEAM-201

IND: Approved Today! 😊

Approval: mid 2027

Price: $375k (Wedbush)

Market is small, so little effect on revenue.

Success IMO will unlock hidden value. I see multiplex editing as a big weapon vs. cancer in 2030 and beyond!
Read 26 tweets
$NTLA and $REGN report initial data from ph1 study of #ATTR for NTLA-2001. All patients across the two doses showed 92-94% TTR reduction at day 28.
#crispr #genomics #genetherapy #biology #biotech
At both dose levels, $NTLA-2001 was generally well tolerated. 2 patients reported transient infusion reactions, which was the only observed treatment-related adverse event.
$NTLA-2001 is an in-vivo administered #genetherapy.
It is one of the first few in-vivo #GeneTherapy being tested. Congrats to the $NTLA and $REGN teams.
Read 4 tweets
"You have the feeling, when you ride, that this animal understands you and you understand this animal. You also have this feeling of mastering this big animal — it makes you feel powerful.” -- Ludovic Orlando @LudovicLorlando greeneracresvaluenetwork.wordpress.com/2022/05/26/dai…
Genetic roots of three mitochondrial diseases identified via new approach
phys.org/news/2022-05-g…
#MitochondrialProteins, #CRISPRCas9, #GeneEditing, #MitochondrialFunction
Read 13 tweets
"God gave you a voice. Use it. If you can see the worth in me, then you can see the worth in everyone you meet. We are all called to serve, as an everyday act of humility, as a habit of mind. To see the worth in every person we serve."-- Elizabeth Bonker greeneracresvaluenetwork.wordpress.com/2022/05/24/dai…
Gene Editing Can Change The Social Behavior of Animals in Unexpected Ways
sciencealert.com/crispr-gene-ed…
#GeneEditing, #VasopressinHormone, #AnimalBehavior, #UnexpectedOutcomes
Deep Visual Proteomics defines single-cell identity and heterogeneity | Nature Biotechnology
nature.com/articles/s4158…
#DeepVisualProteomics, #CellularPhenotypes, #ImageAnalysis, #ArtificialIntelligence
Read 13 tweets
1/As promised & after reading $NTLA latest Q1 2022 financial report here is my analysis regarding @intelliatx latest corporate status. I have focused only on the main issues that I found to be the most interesting & relevant. #CRISPR #GeneEditing #BioTech #FinTwit #Genomics👇
2/NTLA-2001 is the most advanced In-Vivo #CRISPR/#Cas9 #GeneEditing program in $NTLA portfolio & is aimed to treat Transthyretin Amyloidosis - (ATTR). NTLA-2001 could potentially halt & reverse the disease in a “one time” treatment by knocking out the TTR gene with a single dose
3/In February $NTLA has presented an updated clinical data from its Phase 1 study of NTLA-2001 which included 15 patients with ATTR amyloidosis. IMO NTLA-2001 readout looks promising & here is a summary that I wrote shortly after @intelliatx’s presentation of NTLA-2001👇
Read 14 tweets
Daily Bookmarks to GAVNet 03/18/2022 greeneracresvaluenetwork.wordpress.com/2022/03/18/dai…
Protein tweak makes CRISPR gene editing 4,000 times less error-prone
newatlas.com/science/crispr…
#CRISPR, #GeneEditing, #Cas9Protein, #ErrorCorrection
Read 13 tweets
Who's ready for another jab in March? Roll up your sleeve (again) for #Pfizer 1.1:

CEO Albert Bourla, Jan 10, 2022: "And we know that the 3, the 2-dose[s] of the #vaccine, offer very limited protection, if any."

#4IR #BiotechEconomy #GeneEditing #mRNA #Crispr

Thread 👇
Bourla con't: "The 3 doses w/ the #booster, they offer reasonable protection against hospitalization & deaths... Now, we are working on a new version of our vaccine, the 1.1 [] that will cover #Omicron as well."

Bourla: "... we are waiting to have the final results. The vaccine will be ready in March, & [] we'll be able to produce it massively."

Yahoo: "I want to quickly talk about the #kids... under 5... the company has said that it's going to need to be a 3-dose vaccine..."
#biotech
Read 6 tweets
1/10War on virus is about cognitive dissonance. Those of us who stood by silent as minority communities were gentrified through the war on drugs, or profited by it, do not imagine being the targets of an epic urban renewal through lockdown measures and vaccine mandates.
2/10War on virus is about destabilization.  The bulk of wage workers as well as business owners who cater to the establishment must collide with those who have realized that their livelihoods are being destroyed or their businesses are being swallowed by large corporate entities.
3/10Communities are divided.  Family members are divided over fear and uncertainty.  We are being primed for further colonization of humanity and nature.
Read 10 tweets
2/12/21: Newsweek: "Miraculous #mRNA #Vaccines are only the Beginning"

#mRNA vaccines offer "an early look at how the miraculous tools of the #genetics #revolution will transform our #healthcare & our world over the coming years."

#4IR #biotech

newsweek.com/miraculous-mrn…
"...our Promethean technologies, our moment of triumph could set us on a path to disaster. Of all the species that have ever lived, our single group of hominins now has the capacity to remake all of #biology."

#GeneEditing #4IR #Biotech
The new #vaccines are perfect early examples of this "godlike #technology." ... This approach will soon create a whole new platform for fighting cancers & other diseases, as well as for providing enhancements even more profound than #vaccination."

Human #Experiment w/ #mRNA
Read 11 tweets
2/12/21: Newsweek: "Miraculous #mRNA #Vaccines are only the Beginning"

#mRNA vaccines offer "an early look at how the miraculous tools of the #genetics #revolution will transform our #healthcare & our world over the coming years."

#4IR #biotech

newsweek.com/miraculous-mrn…
"...our Promethean technologies, our moment of triumph could set us on a path to disaster. Of all the species that have ever lived, our single group of hominins now has the capacity to remake all of #biology."

#GeneEditing #4IR #Biotech
The new #vaccines are perfect early examples of this "godlike #technology." ... This approach will soon create a whole new platform for fighting cancers & other diseases, as well as for providing enhancements even more profound than #vaccination."

Human #Experiment w/ #mRNA
Read 10 tweets
Daily Bookmarks to GAVNet 05/17/2021 greeneracresvaluenetwork.wordpress.com/2021/05/17/dai…
Battlestar Galactica Lessons from Ransomware to the Pandemic

theinsight.org/p/battlestar-g…

#ransomware #PandemicResponse #LessonsLearned
Female northern elephant seals spend 18 hours a day foraging in deep sea

phys.org/news/2021-05-f…

#FemaleSeals #foraging #BehaviorTracking
Read 10 tweets
Daily Bookmarks to GAVNet 05/15/2021 greeneracresvaluenetwork.wordpress.com/2021/05/15/dai…
Non-hospitalized COVID-19 patients: Low-risk of serious long-term effects, but more visits to doctor

medicalxpress.com/news/2021-05-n…

#COVID19 #LongHaulers #risk
Read 10 tweets
New Concept Weapons #NCW
Directed Energy #Weapons #DEW
Force multiplier
New sword
Invisible card
People’s Liberation Army #PLA
PLA Strategic Support Force #PLASSF
new #technology testing
Disruptive #technologies
#Space Engineering University
#Chinese academic and military
#China
Force multiplier

Intelligent network and electromagnetic spectrum attack and defense weapons

“Computer chip virus” weapon

New-type psychological intervention/warfare weapons
noise intervention
holography display

Nanosatellites for intelligence collection

#China
#ChinaNCW
Read 5 tweets
This is the third edition of my tweetstorms on #GeneTherapy #CellTherapy #GeneEditing. This one compares $SGMO to $CRSP and attempts to look at #GenomeMedicine from the perspectives laid out by C.Woods at ARK This is part one of the series. Pt 2 tomorrow AM 1/20
The charts of both are attached and useful context. $CRSP went public in 2016. The weekly chart is attached and notes the pct ownership of $ARKG $ARKK since CY18. Prior the stock was stagnant below the support/resistance levels show. 2/20
I'm including two charts for $SGMO. Wkly and Mthly. The weekly shows they were pulled along with the #geneediting group The monthly shows this rally/bust cycle is not unique. Compare the SGMO 2017-2018 to CRSP. Pretty similar. More later. 3/20
Read 21 tweets
🌄Good evening everyone!

Welcome to In Conversation with 𝐃𝐫 𝐑 𝐂𝐡𝐢𝐝𝐚𝐦𝐛𝐚𝐫𝐚𝐦, Former Principal Scientific Adviser to Govt. of India, Chairman AEC & Secretary @DAEIndia👥

🗣️Please post your recommendations, comments with #ChatwithRChidambaram
👸👸This live-tweet thread is curated by @AnamZille & @Jengovz on behalf of @spf_in

🌸🌸Opening the session with a warm welcome by @ChagunBasha @DSTCPRIISc @PrinSciAdvGoI
Read 43 tweets
Good evening everyone! 🌇🕕
Welcome to In Conversation with Dr. Renu Swarup @RenuSwarup @DBTIndia

Please post your recommendations, comments with #ChatwithRenuSwarup.
This live-tweet thread is curated by @AnamZille & @Jengovz on behalf of @spf_in 👧👧

Opening the session with a warm welcome 💐💐by @ChagunBasha @DSTCPRIISc @PrinSciAdvGoI
Read 47 tweets
What's up with $SGMO valuation? This thread will try to show some history and the setup for what I still hope to be an outsized move. First worth noting that news will always trump technicals. First here is a month chart I've been using for the company 1/
This being a 10 year chart, it doesn't show how long $SGMO has been around but it does show virtually no trading volume and a 3 yr ceiling on the price as they were in early development stage while trying to get ill-chosen indications into pre/clinic 2/
The first wave $SGMO rally started in 2013 when the ceiling was broken. The company was talking up #GeneEditing #GeneRegulation #HIVcure and #diabetes None were ready but the volume picked up and the first big rally ensued going from around $9 to $20 3/
Read 13 tweets

Related hashtags

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!